HubSpot is a highly scalable CRM platform best suited to growing businesses that can get started with its free plan, and later upgrade to more robust paid options. Its advanced features such as ...

Jake Peterson is Lifehacker’s Tech Editor, and has been covering tech news and how-tos for nearly a decade. His team covers all things technology, including AI, smartphones, computers, game consoles, ...

HubSpot is a comprehensive CRM for companies that want to get a better return on their sales and marketing activities. It allows you to capture and track leads easily while evaluating campaign ...

HubSpot launches an AEO tool inside Marketing Hub to track AI visibility, citations, and competitors. See what this HubSpot news means for marketers. HubSpot has launched a new AEO tool designed to ...

HubSpot has a number of new platform updates, including a new answer engine optimization tool, and more AI-infused Breeze Assistant and Agent capabilities. HubSpot is on a roll for the spring, ...

Get traffic data and keyword intel on competitors instantly. Marketers who put their inbound strategy on the shelf in the past year can now put their Inbound conference mugs and SWAG alongside it.

HubSpot demonstrates solid operational progress, expanding its platform, improving profitability, and gaining traction with larger customers. HUBS is strategically leaning into AI and automation, ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

HubSpot (NYSE: HUBS) is reinventing its growth model around artificial intelligence, and the market may be mispricing what that means for future earnings. If revenue accelerates and margins expand ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...